allo-dendritic-secretome adjuvant therapy (PT Prodia Stem Cell Indonesia)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Nameallo-dendritic-secretome adjuvant therapy (PT Prodia Stem Cell Indonesia)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultNasopharyngeal Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPt. Prodia Stem Cell Indonesia
China Registration ClassN/A

Develop Information

Active CompaniesPt. Prodia Stem Cell Indonesia
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultNasopharyngeal Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A